标题
Trial watch
作者
关键词
-
出版物
OncoImmunology
Volume 1, Issue 9, Pages 1557-1576
出版商
Informa UK Limited
发表日期
2012-11-02
DOI
10.4161/onci.22428
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
- (2012) Valérie Dutoit et al. BRAIN
- MAGE-A antigens as targets in tumour therapy
- (2012) David W. Meek et al. CANCER LETTERS
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen
- (2012) Norihiko Takahashi et al. CANCER SCIENCE
- Reverse Warburg: Straight to cancer
- (2012) Lorenzo Galluzzi et al. CELL CYCLE
- Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas
- (2012) Catherine A Del Vecchio et al. Expert Review of Vaccines
- Cancer vaccines: should we be targeting patients with less aggressive disease?
- (2012) Diane F Hale et al. Expert Review of Vaccines
- T Cell Assays and MIATA: The Essential Minimum for Maximum Impact
- (2012) C.M. Britten et al. IMMUNITY
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
- (2012) K. Odunsi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Louis Pasteur, the Father of Immunology?
- (2012) Kendall A. Smith Frontiers in Immunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
- (2012) Helene Pere et al. OncoImmunology
- Can the exome and the immunome converge on the design of efficient cancer vaccines?
- (2012) Guido Kroemer et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome
- (2011) R. Yerushalmi et al. ANNALS OF ONCOLOGY
- A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens
- (2011) H. Pere et al. BLOOD
- Clinical trial results of the HER-2/neu(E75) vaccine to prevent breast cancer recurrence in high-risk patients
- (2011) Elizabeth A. Mittendorf et al. CANCER
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
- (2011) Alja Oblak et al. Clinical & Developmental Immunology
- Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
- (2011) J. A. Kyte et al. CLINICAL CANCER RESEARCH
- MHC Class I-Presented Tumor Antigens Identified in Ovarian Cancer by Immunoproteomic Analysis Are Targets for T-Cell Responses against Breast and Ovarian Cancer
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- Intra-Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial
- (2011) A. Ribas et al. CLINICAL CANCER RESEARCH
- Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
- (2011) P. F. Brunsvig et al. CLINICAL CANCER RESEARCH
- T cell-independent B cell memory
- (2011) Thierry Defrance et al. CURRENT OPINION IN IMMUNOLOGY
- Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination
- (2011) Junji Kawada et al. INTERNATIONAL JOURNAL OF CANCER
- Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study
- (2011) Renee Vermeij et al. INTERNATIONAL JOURNAL OF CANCER
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
- (2011) Stephen J. Schuster et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma
- (2011) Patrick J Schuler et al. Journal of Translational Medicine
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes
- (2011) D. E. Speiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New concepts in paraneoplastic neurological syndromes
- (2011) J. Honnorat et al. REVUE NEUROLOGIQUE
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Edward Jenner and the Small Pox Vaccine
- (2011) Kendall A. Smith Frontiers in Immunology
- Past, Present, and Future of Molecular and Cellular Oncology
- (2011) Lorenzo Galluzzi et al. Frontiers in Oncology
- Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond
- (2010) C. M. Britten et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
- (2010) Akihiro Miyazaki et al. CANCER SCIENCE
- Results from a Phase I Clinical Study of the Novel Ii-Key/HER-2/neu(776-790) Hybrid Peptide Vaccine in Patients with Prostate Cancer
- (2010) S. A. Perez et al. CLINICAL CANCER RESEARCH
- High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma
- (2010) J. Greiner et al. HAEMATOLOGICA
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Dendritic Cells Induce Regulatory T Cell Proliferation through Antigen-Dependent and -Independent Interactions
- (2010) T. Zou et al. JOURNAL OF IMMUNOLOGY
- Immunogenicity for CD8+ and CD4+ T Cells of 2 Formulations of an Incomplete Freundʼs Adjuvant for Multipeptide Melanoma Vaccines
- (2010) Craig L. Slingluff et al. JOURNAL OF IMMUNOTHERAPY
- Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
- (2010) Antonia Busse et al. Journal of Translational Medicine
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- WT1 peptide immunotherapy for cancer in children and young adults
- (2010) Yoshiko Hashii et al. PEDIATRIC BLOOD & CANCER
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
- (2009) U. Keilholz et al. BLOOD
- EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma
- (2009) Bryan D. Choi et al. BRAIN PATHOLOGY
- BCR/ABL-specific CD8+ T cells can be detected from CML patients, but are only expanded from healthy donors
- (2009) Sylvie Rusakiewicz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
- (2009) Ichiya Honma et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design
- (2009) L. M. Ebert et al. CANCER RESEARCH
- Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
- (2009) Koji Kono et al. CANCER SCIENCE
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- (2009) Shigeru Yutani et al. CANCER SCIENCE
- Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
- (2009) Hirotsugu Uemura et al. CANCER SCIENCE
- Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
- (2009) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy
- (2009) Preeta Tyagi et al. Clinical Lung Cancer
- “MIATA”—Minimal Information about T Cell Assays
- (2009) Sylvia Janetzki et al. IMMUNITY
- Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors
- (2009) Pravin T.P. Kaumaya et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination With Agonist Peptide PSA: 154-163 (155L) Derived From Prostate Specific Antigen Induced CD8 T-Cell Response to the Native Peptide PSA: 154-163 But Failed to Induce the Reactivity Against Tumor Targets Expressing PSA
- (2009) Diana V. Kouiavskaia et al. JOURNAL OF IMMUNOTHERAPY
- Vaccination of Melanoma Patients With Melan-A/Mart-1 Peptide and Klebsiella Outer Membrane Protein P40 as an Adjuvant
- (2009) Danielle Lienard et al. JOURNAL OF IMMUNOTHERAPY
- Novel Immunogenic HLA-A*0201-restricted Epidermal Growth Factor Receptor-specific T-cell Epitope in Head and Neck Cancer Patients
- (2009) Pedro A. Andrade Filho et al. JOURNAL OF IMMUNOTHERAPY
- Longterm Followup Assessment of a HER2/neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients
- (2009) Jeremy D. Gates et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer
- (2009) Susan Feyerabend et al. PROSTATE
- A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
- (2009) Lesley Rees et al. TRANSPLANTATION
- Carcinomas of an unknown primary site: a curable disease?
- (2008) A. Levy et al. ANNALS OF ONCOLOGY
- The Biochemistry of Somatic Hypermutation
- (2008) Jonathan U. Peled et al. Annual Review of Immunology
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Alternative Activation of Macrophages: An Immunologic Functional Perspective
- (2008) Fernando O. Martinez et al. Annual Review of Immunology
- Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
- (2008) G. G. Kenter et al. CLINICAL CANCER RESEARCH
- Functional genomics of cancer
- (2008) Edison T Liu CURRENT OPINION IN GENETICS & DEVELOPMENT
- Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41
- (2008) Christoph S. Klade et al. GASTROENTEROLOGY
- Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
- (2008) Hisashi Wada et al. INTERNATIONAL JOURNAL OF CANCER
- Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
- (2008) Paola Nisticò et al. INTERNATIONAL JOURNAL OF CANCER
- Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients
- (2008) Julien Fourcade et al. JOURNAL OF IMMUNOTHERAPY
- Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
- (2008) Shuichi Izumoto et al. JOURNAL OF NEUROSURGERY
- Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer
- (2008) Tetsuhiro Tsuruma et al. Journal of Translational Medicine
- Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study
- (2008) A. A. McCormick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More